| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PAIN.2007.06.016 |
| P698 | PubMed publication ID | 17693023 |
| P2093 | author name string | Patrick W Mantyh | |
| Ryan J Buus | |||
| Jack L Lewis | |||
| Michael A Kuskowski | |||
| Christopher M Peters | |||
| Joseph R Ghilardi | |||
| Kyle G Halvorson | |||
| Katie T Freeman | |||
| Juan M Jimenez-Andrade | |||
| Nathan J Koewler | |||
| Lucy J Sullivan | |||
| Carl D Martin | |||
| Christina M Barthold | |||
| P2860 | cites work | An estimate of the worldwide prevalence and disability associated with osteoporotic fractures | Q36597363 |
| P433 | issue | 1-3 | |
| P921 | main subject | bone fracture | Q68833 |
| P304 | page(s) | 183-196 | |
| P577 | publication date | 2007-08-10 | |
| P1433 | published in | Pain | Q2317902 |
| P1476 | title | Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture | |
| P478 | volume | 133 |
| Q51529943 | A multiple-dose toxicity study of tanezumab in cynomolgus monkeys. |
| Q33779598 | A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain. |
| Q92153883 | Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model |
| Q35064559 | Antagonism of nerve growth factor-TrkA signaling and the relief of pain |
| Q89562296 | Anti-nerve growth factor does not change physical activity in normal young or aging mice but does increase activity in mice with skeletal pain |
| Q26746194 | Anti-nerve growth factor in pain management: current evidence |
| Q38903010 | Anti-nerve growth factor therapy increases spontaneous day/night activity in mice with orthopedic surgery-induced pain |
| Q58112374 | Antinerve growth factor monoclonal antibodies for the control of pain in dogs and cats |
| Q34356398 | Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain |
| Q37398720 | Capsaicin-sensitive sensory nerve fibers contribute to the generation and maintenance of skeletal fracture pain |
| Q30831131 | Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain |
| Q87417860 | Early, middle, or late administration of zoledronate alleviates spontaneous nociceptive behavior and restores functional outcomes in a mouse model of CFA-induced arthritis |
| Q36881864 | Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. |
| Q46155875 | Extracellular pH and neuronal depolarization serve as dynamic switches to rapidly mobilize trkA to the membrane of adult sensory neurons. |
| Q55264146 | First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain. |
| Q54109841 | Functional effects of TrkA inhibition on system xC--mediated glutamate release and cancer-induced bone pain. |
| Q88523823 | GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain |
| Q47111283 | Immunohistochemical localization of nerve growth factor, tropomyosin receptor kinase A, and p75 in the bone and articular cartilage of the mouse femur. |
| Q30482277 | MAP kinase and pain |
| Q58102355 | Mechanisms Underlying Bone and Joint Pain |
| Q33610520 | Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain. |
| Q57790366 | Mechanisms that drive bone pain across the lifespan |
| Q41684342 | Molecular Mechanisms That Contribute to Bone Marrow Pain |
| Q42325445 | NGF - the TrkA to successful pain treatment |
| Q34617294 | NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use |
| Q37803223 | Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis |
| Q93076198 | Nerves in Bone: Evolving Concepts in Pain and Anabolism |
| Q36067194 | Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint |
| Q89287365 | New Insights in Understanding and Treating Bone Fracture Pain |
| Q35701568 | New advances in musculoskeletal pain. |
| Q30657180 | Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor |
| Q35421746 | Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain |
| Q38631467 | Repeated administration of mazindol reduces spontaneous pain-related behaviors without modifying bone density and microarchitecture in a mouse model of complete Freund's adjuvant-induced knee arthritis. |
| Q36245918 | Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice |
| Q41362866 | Spinal nociceptive transmission by mechanical stimulation of bone marrow. |
| Q34486451 | Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers |
| Q37827172 | Targeted treatment of pruritus: a look into the future |
| Q50060345 | The Changing Sensory and Sympathetic Innervation of the Young, Adult and Aging Mouse Femur |
| Q26747520 | The Physiology of Bone Pain. How Much Do We Really Know? |
| Q28388389 | The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain |
| Q35040554 | The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain |
| Q102220473 | The evolution of nerve growth factor inhibition in clinical medicine |
| Q34803161 | The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. |
| Q34402192 | The neurobiology of skeletal pain |
| Q35676163 | The pathophysiology of acute pain: animal models |
| Q37418810 | Transient receptor potential vanilloid 1-immunoreactive innervation increases in fractured rat femur |
| Q37381681 | Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative |
| Q37289615 | TrkB signaling is required for both the induction and maintenance of tissue and nerve injury-induced persistent pain |
Search more.